An update on the current genomic landscape of breast implant-associated anaplastic large cell lymphoma

Sean Harrop*, Neha Mehta-Shah, Criselle Dsouza, Ella Thompson, Anand Deva, Henry Miles Prince

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    1 Citation (Scopus)
    79 Downloads (Pure)

    Abstract

    Breast implant-associated lymphoma (BIA-ALCL) is a rare subtype of anaplastic large-cell lymphoma associated with breast prostheses. Most patients present with a localised periprosthetic effusion and are managed with removal of the implant and surrounding capsule. Less commonly, the lymphoma can form a mass associated with the capsule and rarely can present with disseminated disease. Recent series characterising the genomic landscape of BIA-ALCL have led to insights into the mechanisms of lymphomagenesis. Constitutive JAK/STAT pathway activation has emerged as a likely key component while, more recently, aberrancies in epigenetic regulators have been reported. This review describes the genomic characterisation reported to date and the insight these findings have provided into this rare entity.

    Original languageEnglish
    Article number4921
    Pages (from-to)1-9
    Number of pages9
    JournalCancers
    Volume13
    Issue number19
    DOIs
    Publication statusPublished - 1 Oct 2021

    Bibliographical note

    Copyright the Author(s) 2021. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

    Keywords

    • Breast implants
    • Epigenetic
    • JAK/STAT

    Fingerprint

    Dive into the research topics of 'An update on the current genomic landscape of breast implant-associated anaplastic large cell lymphoma'. Together they form a unique fingerprint.

    Cite this